Search Blog
November 2018


Archive for November 19th, 2018

Subscribe Technologies Introduces Gingerly Marketplace

By Subscribe Technologies Inc VANCOUVER, BC / ACCESSWIRE / November 19, 2018 / Subscribe Technologies Inc. (CSE: SAAS, OTCQB: SRBBF, Frankfurt: 6GQ) (“Subscribe” or “the Company”) is pleased to announce its Gingerly Marketplace App development lineup. The Subscribe development team is now finalizing the Gingerly Marketplace along with paid add-on upgrades available to users to […]

Riot Blockchain Releases 3rd Quarter Results

By Riot Blockchain, Inc. Company Generates $2.4 Million in Revenue for the Quarter on the Production of 319 Bitcoins and 1,182 Litecoin CASTLE ROCK, CO / ACCESSWIRE / November 19, 2018 / Riot Blockchain, Inc. (NASDAQ: RIOT) (“the Company”) announced the filing of its unaudited results for the third quarter on Form 10-Q for the […]

ADM Tronics Reports Financial Results for Second Quarter of Fiscal Year 2019

By ADM Tronics Unlimited Inc. NORTHVALE, NJ / ACCESSWIRE / November 19, 2018 / ADM Tronics Unlimited, Inc. (OTCQB: ADMT), a technology-based developer and manufacturer of innovative technologies and products, today announced results for its second fiscal quarter ended September 30, 2018 of Fiscal Year 2019. As previously announced, ADMT has been redirecting more of […]

Oxbridge Re Holdings Limited Announces Term Extension of Warrants

By Oxbridge Re Holdings Limited GRAND CAYMAN, Cayman Islands / ACCESSWIRE / November 19, 2018 / Oxbridge Re Holdings Limited (OXBR), a provider of reinsurance solutions primarily to property and casualty insurers in the Gulf Coast region of the United States, announced today an extension to the term for exercise of its publicly traded warrants […]

Dynasty Gold Announces Completion of Mapping and Prospecting Program at the Thundercloud Property, Ontario

By Dynasty Gold Corp. VANCOUVER, BC / ACCESSWIRE / November 19, 2018 / Dynasty Gold Corp. (TSX-V: DYG) (FWB: D5G) (OTC PINK: DGDCF) (“Dynasty” or the “Company”) is pleased to announce completion of the mapping and rock sampling program at the Thundercloud property, optioned from Teck Resources Limited (“Teck”) early this year (see press release […]

What Happens When You Can’t Pay Medical Bills

By Resolvly, LLC How Resolvly Helps When You Can’t Pay Medical Bills LOS ANGELES, CA / ACCESSWIRE / November 19, 2018 / Are your medical bills mounting? Most American families are finding it difficult to keep up with high deductible costs and can’t afford to pay their never-ending medical bills. Late medical bill payments make […]

Blockchain Holdings Announces Private Placement Offering

By Blockchain Holdings Ltd. TORTOLA, BRITISH VIRGIN ISLANDS / ACCESSWIRE / November 19, 2018 / Blockchain Holdings Ltd. (the “Company”) (CSE: BCX) proposes to raise up to C$1,000,000 by way of a non-brokered private placement offering of up to 2,000,000 shares at a price of C$0.50 per share of the Company (the “Offering“). The Company […]

Blackhawk Bancorp, Inc. Declares Dividend on Common Stock

By Blackhawk Bancorp, Inc. BELOIT, WI / ACCESSWIRE / November 19, 2018 / Blackhawk Bancorp, Inc. (OTCQX: BHWB) reports that its Board of Directors has declared a cash dividend on the Company’s common stock. Shareholders of record as of December 7, 2018 will be paid a dividend of $0.10 per share on December 21, 2018. […]

Are You One of the Hottest Startups at CES 2019?

By ShowStoppers Seventh Edition of ShowStoppers® Launchit is Where Eureka Park Exhibitors Pitch the Most-investable Ideas, Entrepreneurs & Companies ARLINGTON, VA / ACCESSWIRE / November 19, 2018 / The Consumer Technology Association™ (CTA), ShowStoppers® and the New York Angels today announced they are partnering again to help entrepreneurs and startups raise early seed funding – […]

MorphoSys Announces Its Licensee Janssen Initiated a Phase 2 Study (NOVA) to Evaluate Guselkumab in Hidradenitis Suppurativa

By MorphoSys AG PLANEGG/MUNICH, GERMANY / ACCESSWIRE / November 19, 2018 / MorphoSys AG (FSE: MOR; Prime Standard Segment, MDAX & TecDAX; NASDAQ: MOR) announced today that its licensee Janssen Research & Development, LLC (Janssen) initiated a phase 2 clinical study of guselkumab in patients with moderate to severe hidradenitis suppurativa (HS), a chronic skin […]